Inventor · disambiguated record
Tie Q. Wei
Also filed as: WEI TIE · WEI TIE Q · WEI TIE QUAN
41 granted patents·23 pending applications·258 citations·filing 1998–2025
97Inventor score
Files withSIEMENS HEALTHCARE DIAGNOSTICS INC40WEI TIE Q8SIEMENS HEALTHCARE DIAGNOSTICS7DADE BEHRING INC5WEI TIE QUAN3
Top patents by PatentIndex Score
64 records- 0197US7842475B2Stabilization of solid support assay reagentsSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2008·Granted Nov 30, 2010·44 cites·17 claims
- 0293US11377483B2Sandwich assay design for small moleculesSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2020·Granted Jul 5, 2022·2 cites·13 claims
- 0393US11313855B2Methods and compositions for removing biotin interference from assays using conjugated molecular trapsSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2019·Granted Apr 26, 2022·4 cites·19 claims
- 0490US11287429B2Compositions, kits, and methods for multiplex assays to correct for biotin interference in target analyte measurementsSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2019·Granted Mar 29, 2022·2 cites·11 claims
- 0588US11592439B2Pretreatment agent in non-agglutination assaysSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2020·Granted Feb 28, 2023·2 cites·16 claims
- 0687US7186518B2Method and composition useful for determining FK 506DADE BEHRING INC·Filed 2003·Granted Mar 6, 2007·70 cites·8 claims
- 0787US2024426814A1Pretreatment agent in non-agglutination assaysSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2024·Application pending·0 cites
- 0886US2024377406A1Compositions, kits, and methods for multiplex assays to correct for biotin interference in target analyte measurementsSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2024·Application pending·0 cites
- 0985US2024351033A1Compositions, devices, and methods of mitigating lipoprotein interference in in vitro diagnostic assays for hydrophobic analytesSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2024·Application pending·0 cites
- 1084US2024159781A1Sandwich assay for small moleculesSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2024·Application pending·0 cites
- 1183US8586322B2Sandwich assay for immunosuppressant drugsWEI TIE QUAN·Filed 2012·Granted Nov 19, 2013·5 cites·12 claims
- 1282US6284472B1Method for extending the range of an immunoassayDADE BEHRING INC·Filed 1999·Granted Sep 4, 2001·49 cites·14 claims
- 1382US2025027947A1Kits, microfluidics devices, and methods for performing biotin assaysSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2024·Application pending·0 cites
- 1481US12111310B2Pretreatment agent in non-agglutination assaysSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2023·Granted Oct 8, 2024·0 cites·4 claims
- 1581US9804176B2Assays for vitamin D epimersSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2015·Granted Oct 31, 2017·2 cites·12 claims
- 1680US12053775B2Compositions, devices, and methods of mitigating lipoprotein interference in in vitro diagnostic assays for hydrophobic analytesSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2022·Granted Aug 6, 2024·0 cites·12 claims
- 1780US9121859B2Compounds and methods for determination of FKBP-binding immunosuppressant drugsSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2012·Granted Sep 1, 2015·3 cites·15 claims
- 1879US2024208996A1Binding competitors for use in macrophilin-binding pharmaceutical assays and methods of use thereofSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2024·Application pending·0 cites
- 1978US7172906B2Reduction of non-specific binding in assaysDADE BEHRING INC·Filed 2004·Granted Feb 6, 2007·14 cites·21 claims
- 2077US12099063B2Compositions, kits, and methods for multiplex assays to correct for biotin interference in target analyte measurementsSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2022·Granted Sep 24, 2024·0 cites·14 claims
- 2175US8809003B2Reduction in false results in assay measurementsSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2012·Granted Aug 19, 2014·2 cites·10 claims
- 2274US12099055B2Methods and compositions for removing biotin interference from assays using conjugated molecular trapsSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2022·Granted Sep 24, 2024·0 cites·7 claims
- 2374US11913965B2Sandwich assay for small moleculesSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2021·Granted Feb 27, 2024·0 cites·11 claims
- 2472US2025180585A1Methods for detection of aberrant results caused by incomplete dispersion of immunoassay reagentSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2025·Application pending·0 cites
- 2571US11358143B2Compositions, devices, and methods of mitigating lipoprotein interference in in vitro diagnostic assays for hydrophobic analytesSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2020·Granted Jun 14, 2022·0 cites·16 claims
- 2670US12259381B2Methods and compositions for removing biotin interference from assays using molecular trapsSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2019·Granted Mar 25, 2025·0 cites·8 claims
- 2770US9746484B2Binding partners specific for vitamin D epimers in vitamin D assaysSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2015·Granted Aug 29, 2017·1 cites·12 claims
- 2870US7790401B2Methods for detection of immunosuppressant drugsSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2007·Granted Sep 7, 2010·2 cites·11 claims
- 2970US7488608B2Reduction of non-specific binding in assaysSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2007·Granted Feb 10, 2009·2 cites·12 claims
- 3070US7039561B2Outlier rejection method in an automatic clinical analyzerDADE BEHRING INC·Filed 2004·Granted May 2, 2006·3 cites·3 claims
- 3169US9618523B2Methods and reagents for determining isomeric analytesWEI TIE Q·Filed 2013·Granted Apr 11, 2017·1 cites·4 claims
- 3268US12247987B2Methods for detection of aberrant results caused by incomplete dispersion of immunoassay reagentSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2019·Granted Mar 11, 2025·0 cites·23 claims
- 3368US11958863B2Binding competitors for use in macrophilin-binding pharmaceutical assays and methods of use thereofSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2019·Granted Apr 16, 2024·0 cites·20 claims
- 3468US8329424B2Reduction in false results in assay measurementsWEI TIE Q·Filed 2010·Granted Dec 11, 2012·1 cites·10 claims
- 3568US7642338B2Tacrolimus standard and methods of using sameSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2006·Granted Jan 5, 2010·2 cites·12 claims
- 3668US2019128877A1Pretreatment agent in non-agglutination assaysSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2018·Application pending·0 cites
- 3768US2025147009A1Methods and compositions for removing biotin interference from assays using molecular trapsSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2025·Application pending·0 cites
- 3866US6277584B1Method for calibrating a chemical analyzer with improved accuracy at low signal levelsDADE BEHRING INC·Filed 1998·Granted Aug 21, 2001·43 cites·14 claims
- 3965US12140596B2Kits, microfluidics devices, and methods for performing biotin assaysSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2019·Granted Nov 12, 2024·0 cites·13 claims
- 4065US9815907B2Binding partners specific for vitamin D epimersSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2015·Granted Nov 14, 2017·1 cites·6 claims
- 4163US2025138011A1Compositions, kits, and methods for duplex immunoassay for anti-sars-cov-2 antibodiesSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2022·Application pending·0 cites
- 4262US7910378B2Methods for detection of hydrophobic drugsSIEMENS HEALTHCARE DIAGNOSTICS·Filed 2007·Granted Mar 22, 2011·2 cites·9 claims
- 4362US2016313310A1Pretreatment agent in non-agglutination assaysSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2014·Application pending·0 cites
- 4462US2025147019A1Biotin-trap beads and methods of production and use thereofSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2022·Application pending·0 cites
- 4561US2018306828A1Sandwich assay for small moleculesSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2016·Application pending·0 cites
- 4659US8153594B2Tacrolimus standard and methods of using sameWEI TIE Q·Filed 2009·Granted Apr 10, 2012·0 cites·9 claims
- 4759US8071317B2Methods for detection of hydrophobic drugsWEI TIE Q·Filed 2011·Granted Dec 6, 2011·1 cites·7 claims
- 4858US2017160295A1Methods and reagents for determining isomeric analytesSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2017·Application pending·0 cites
- 4956US2024168022A1Compositions, kits, and methods for anti-microbial serology assays using anti-human immunoglobulin antibodySIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2021·Application pending·0 cites
- 5056US2023152318A1Compositions, kits, and methods for anti-microbial serology assays using anti-human immunoglobulin antibodySIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →